Plasma Uric Acid, Lactate, and Osmolality in Colorectal Cancer
Source abstract
Abstract
A complex evaluation of colorectal cancer (CRC) in relation to screening, diagnosis, stage determination, prognosis, and treatment requires valuable biomarkers. The aim of this study was to measure selected biomarkers—uric acid (UA), lactate, Na+, Cl−, and osmolality—in CRC patients and to assess their diagnostic value to distinguish between CRC and healthy controls. Plasma lactate (2.21 ± 0.11 vs. 2.88 ± 0.19, p < 0.01), Na+ (130.79 ± 0.42 vs. 133.23 ± 0.25, p < 0.001), Cl− (102.59 ± 0.45 vs. 103.94 ± 0.23, p < 0.01), and osmolality (266.44 ± 0.86 vs. 271.72 ± 0.62, p < 0.001) were found to be significantly lower in CRC patients as compared to the healthy controls group. Among them, with satisfactory diagnostic potential, were plasma Na+ concentrations and osmolality (AUCNa+ = 0.752, p < 0.0001; AUCosmolality = 0.757, p < 0.05), respectively. UA concentrations were detected at higher concentrations in CRC patients (333.67 ± 13.05 vs. 295.88 ± 13.78, p < 0.05). The results of this study contribute to the elucidation of molecular mechanisms of CRC pathogenesis and the role of studied metabolic parameters in this process. Plasma uric acid, lactate, and osmolality parameters can be used for screening and monitoring colorectal cancer. Further studies are required to elucidate the molecular mechanisms of their action in cancer development. The action of circulating plasma lactate may be different from those locally produced in the tumor microenvironment.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Liver Disease Diagnosis and Treatment · Alcohol Consumption and Health Effects · Diabetes and associated disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biochemistry, Molecular Medicine and Nutrigenomics, Faculty of Pharmacy, Medical University “Prof. Dr. Paraskev Stoyanov”, 9002 Varna, Bulgaria
Department of General and Operative Surgery, Faculty of Medicine, Medical University “Prof. Dr. Paraskev Stoyanov”, 9002 Varna, Bulgaria
Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 40-055 Katowice, Poland
Department of Community Pharmacy, Faculty of Pharmaceutical Sciences, Medical University of Silesia in Katowice, 40-055 Katowice, Poland
Department of Biology, Faculty of Pharmacy, Medical University “Prof. Dr. Paraskev Stoyanov”, 9002 Varna, Bulgaria
Funding
European Union–NextGenerationEU through the National Recovery and Resilience Plan of the Republic of Bulgaria · Science Fund, Medical University of Varna, Bulgaria
References (69)
Show source-provided references
1. Cancer statistics, 202210.3322/caac.21708 ↗
2. Global patterns and trends in colorectal cancer incidence and mortality10.1136/gutjnl-2015-310912 ↗
3. Global Burden of Disease 2019 Cancer Collaboration, Kocarnik, J.M., Compton, K., Dean, F.E., Fu, W., Gaw, B.L., Harvey, J.D., Henrikson, H.J., Lu, D., and Pennini, A. (2022). Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol., 8, 420–444.
4. Lin, X., and Li, H. (2021). Obesity: Epidemiology, Pathophysiology, and Therapeutics. Front. Endocrinol., 12.10.3389/fendo.2021.706978 ↗
5. Obesity as a disease: No lightweight matter10.1111/j.1467-789X.2004.00144.x ↗
6. Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality10.1152/physrev.00030.2014 ↗
7. Ogunwobi, O.O., Mahmood, F., and Akingboye, A. (2020). Biomarkers in Colorectal Cancer: Current Research and Future Prospects. Int. J. Mol. Sci., 21.10.3390/ijms21155311 ↗
8. Allegrini, S., Garcia-Gil, M., Pesi, R., Camici, M., and Tozzi, M.G. (2022). The Good, the Bad and the New about Uric Acid in Cancer. Cancers, 14.10.3390/cancers14194959 ↗
9. Uric Acid Produces an Inflammatory Response through Activation of NF-κB in the Hypothalamus: Implications for the Pathogenesis of Metabolic Disorders10.1038/srep12144 ↗
10. Yang, K., Xu, J., Fan, M., Tu, F., Wang, X., Ha, T., Williams, D.L., and Li, C. (2020). Lactate Suppresses Macrophage Pro-Inflammatory Response to LPS Stimulation by Inhibition of YAP and NF-κB Activation via GPR81-Mediated Signaling. Front. Immunol., 11.10.3389/fimmu.2020.587913 ↗
11. Lactate reduces liver and pancreatic injury in Toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity10.1053/j.gastro.2014.03.014 ↗
12. Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Non-alcoholic Steatohepatitis10.1155/2016/8603164 ↗
13. Yanai, H., Adachi, H., Hakoshima, M., and Katsuyama, H. (2021). Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease. Int. J. Mol. Sci., 22.10.3390/ijms22179221 ↗
14. Uric acid secretion from adipose tissue and its increase in obesity10.1074/jbc.M113.485094 ↗
15. Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity10.1016/j.cmet.2007.01.005 ↗
16. Association of serum uric acid with visceral, subcutaneous and hepatic fat quantified by magnetic resonance imaging10.1038/s41598-020-57459-z ↗
17. Studies on the impaired metabolism of uric acid in obese subjects: Marked reduction of renal urate excretion and its improvement by a low-calorie diet
18. Serum uric acid levels are associated with obesity but not cardio-cerebrovascular events in Chinese inpatients with type 2 diabetes10.1038/srep40009 ↗
19. Association between Serum Uric Acid Level and Body Mass Index in Sex- and Age-Specific Groups in Southwestern China10.4158/EP-2018-0426 ↗
20. Serum Uric Acid Levels and the Risk of Obesity: A Longitudinal Population-Based Epidemiological Study10.7754/Clin.Lab.2017.170311 ↗
21. Jiang, M., Ren, L., Chen, S., and Li, G. (2021). Serum Uric Acid Levels and Risk of Eight Site-Specific Cancers: A Mendelian Randomization Study. Front. Genet., 12.10.3389/fgene.2021.608311 ↗
22. Effect of serum uric acid and gout on the incidence of colorectal cancer: A meta-analysis10.1016/j.amjms.2023.11.013 ↗
23. Lactate metabolism in human health and disease10.1038/s41392-022-01151-3 ↗
24. Zhou, H.C., Yu, W.W., Yan, X.Y., Liang, X.Q., Ma, X.F., Long, J.P., Du, X.Y., Mao, H.Y., and Liu, H.B. (2022). Lactate-driven macrophage polarization in the inflammatory microenvironment alleviates intestinal inflammation. Front. Immunol., 13.10.3389/fimmu.2022.1013686 ↗
25. Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity10.1038/s41467-022-32521-8 ↗
26. Reexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect
27. Cai, M., Wan, J., Cai, K., Song, H., Wang, Y., Sun, W., and Hu, J. (2022). Understanding the Contribution of Lactate Metabolism in Cancer Progress: A Perspective from Isomers. Cancers, 15.10.3390/cancers15010087 ↗
28. Wei, Y., Xu, H., Dai, J., Peng, J., Wang, W., Xia, L., and Zhou, F. (2018). Prognostic Significance of Serum Lactic Acid, Lactate Dehydrogenase, and Albumin Levels in Patients with Metastatic Colorectal Cancer. BioMed Res. Int., 2018.10.1155/2018/1804086 ↗
29. Lactate production in adipose tissue: A regulated function with extra-adipose implications10.1096/fasebj.6.7.1563593 ↗
30. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR8110.1074/jbc.M806409200 ↗
31. An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR8110.1016/j.cmet.2010.02.012 ↗
32. Lactate Can Be a Marker of Metabolic Syndrome in Severe Obesity?10.1590/0102-672020210001e1579 ↗
33. Hypoxia and adipocyte physiology: Implications for adipose tissue dysfunction in obesity10.1146/annurev-nutr-071812-161156 ↗
34. Lactate Is a Key Mediator that Links Obesity to Insulin Resistance via Modulating Cytokine Production from Adipose Tissue10.2337/db21-0535 ↗
35. Inadequate Hydration, BMI, and Obesity among US Adults: NHANES 2009–201210.1370/afm.1951 ↗
36. The role of obesity in the relation between total water intake and urine osmolality in US adults, 2009–201210.3945/ajcn.116.137414 ↗
37. Association of Sodium Excretion With Metabolic Syndrome, Insulin Resistance, and Body Fat10.1097/MD.0000000000001650 ↗
38. The association between dietary sodium intake and obesity in adults by sodium intake assessment methods: A review of systematic reviews and re-meta-analysis10.4162/nrp.2023.17.2.175 ↗
39. Consumption of dietary salt measured by urinary sodium excretion and its association with body weight status in healthy children and adolescents10.1017/S1368980011002138 ↗
40. Salt intake is related to soft drink consumption in children and adolescents: A link to obesity?10.1161/HYPERTENSIONAHA.107.100990 ↗
41. Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy10.18632/oncotarget.13372 ↗
42. Managing hyponatremia in lung cancer: Latest evidence and clinical implications10.1177/1758834017736210 ↗
43. Electrolyte disorders in cancer patients: A systematic review
44. Friend or Foe? An Unrecognized Role of Uric Acid in Cancer Development and the Potential Anticancer Effects of Uric Acid-lowering Drugs10.7150/jca.46200 ↗
45. Asymptomatic hyperuricaemia: A silent activator of the innate immune system10.1038/s41584-019-0334-3 ↗
46. Urate-induced immune programming: Consequences for gouty arthritis and hyperuricemia10.1111/imr.12833 ↗
47. Signaling pathways in uric acid homeostasis and gout: From pathogenesis to therapeutic interventions10.1016/j.intimp.2024.111932 ↗
48. High serum uric acid may associate with the increased risk of colorectal cancer in females: A prospective cohort study10.1002/ijc.33807 ↗
49. Hyperuricemia at the Time of Diagnosis is a Factor for Poor Prognosis in Patients with Stage II and III Colorectal Cancer (Uric Acid and Colorectal Cancer)
50. The relationship between serum uric acid and colorectal cancer: A prospective cohort study10.1038/s41598-022-20357-7 ↗
51. Hyperuricemia is a Adverse Prognostic Factor for Colon Cancer Patients10.2147/IJGM.S314834 ↗
52. Relationship between serum uric acid and metastatic and nonmetastatic rectal cancer patients with undergoing no chemotherapy10.1097/MD.0000000000005463 ↗
53. Uric acid effects on glutathione metabolism estimated by induction of glutamate-cysteine ligase, glutathione reductase and glutathione synthetase in mouse J744A.1 macrophage cell line10.3897/folmed.64.e65507 ↗
54. Halperin Kuhns, V.L., and Woodward, O.M. (2020). Sex Differences in Urate Handling. Int. J. Mol. Sci., 21.10.3390/ijms21124269 ↗
55. Yu, W., and Cheng, J.D. (2020). Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective. Front. Pharmacol., 11.10.3389/fphar.2020.582680 ↗
56. Syndrome of inappropriate secretion of anti-diuretic hormone (SIADH) as an initial presenting sign of non small cell lung cancer-case report and literature review
57. Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: Case report and literature review10.1023/A:1008369932384 ↗
58. An inappropriate ADH syndrome and Lung cancer diagnosis in a patient with isolated hyponatremia
59. Prognostic impact of hyponatraemia in patients with colorectal cancer10.1111/codi.12878 ↗
60. Hyponatremia in cancer patients10.5301/tj.5000257 ↗
61. A prospective study on hyponatraemia in medical cancer patients: Epidemiology, aetiology and differential diagnosis10.1007/s005200050284 ↗
62. Prevalence of hyponatremia and association with mortality: Results from NHANES10.1016/j.amjmed.2013.07.021 ↗
63. Hyponatremia, all-cause mortality, and risk of cancer diagnoses in the primary care setting: A large population study10.1016/j.ejim.2016.07.028 ↗
64. Hyponatraemia in cancer: Association with type of cancer and mortality10.1111/ecc.12187 ↗
65. The burden of hyponatremia and hypercalcemia on hospitalizations and mortality in lung cancer patients in the United States: An analysis of nationwide inpatient database
66. Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma10.1038/sj.bjc.6605563 ↗
67. The occurrence of hyponatremia in SCLC and the influence on prognosis: A retrospective study of 453 patients treated in a single institution in a 10-year period10.1016/j.lungcan.2009.05.015 ↗
68. The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Cancer Database Consortium10.1016/j.eururo.2013.10.013 ↗
69. Regulation of osmolality for cancer treatment10.1007/s12576-017-0528-x ↗